USE OF EXOGENOUS INSULIN OR SULFONYLUREAS IS A POTENTIAL RISK FACTOR FOR HEPTOCELLULAR CARCINOMA IN HEPATITIS C PATIENTS WITH DIABETES MELLITUS

被引：0
|
作者：
Taniguchi, Eitarc [1 ]
Kawaguchi, Takumi [1 ,2 ]
Morita, Yasuyo [3 ]
Sata, Michio [1 ,2 ]
机构：
[1] Kurume Univ, Sch Med, Dept Med, Kurume, Fukuoka 830, Japan
[2] Kurume Univ, Sch Med, Dept Digest Dis Informat & Res, Kurume, Fukuoka 830, Japan
[3] Nagata Hosp, Yanagawa, Japan
来源：
HEPATOLOGY | 2008年 / 48卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
469
引用
收藏
页码：516A / 517A
页数：2
相关论文
共 50 条
  • [31] Using Pharmacoepidemiology to Examine the Interplay of Sulfonylureas and Infection Risk in Patients With Diabetes Mellitus
    Wu, Yu-ying
    Lin, I-Fan
    Chen, Kuan-Hua
    Wang, Hsi-Hao
    Huang, Chun-Kai
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2025,
  • [32] The Cardiovascular Risk of Sulfonylureas on Newly Diagnosed Type II Diabetes Mellitus Patients
    Wu, Yi-ting
    Gau, Churn-Shiouh
    DRUG SAFETY, 2009, 32 (10) : 945 - 946
  • [33] Risk of repeated use of needles for insulin pen needle in patients with diabetes mellitus
    Misnikova, I. V.
    Dreval, A. V.
    Gubkina, V. A.
    Rusanova, E. V.
    DIABETOLOGIA, 2009, 52 : S378 - S378
  • [34] Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or exogenous insulin compared to metformin
    Bowker, SL
    Majumdar, SR
    Veugelers, P
    Johnson, JA
    DIABETES, 2005, 54 : A128 - A129
  • [35] Proinflammatory Cytokines and Cardiovascular Risk in Patients with Diabetes Mellitus and Chronic Hepatitis C
    Dragut, Ramona Maria
    Rusu, Emilia
    Nan, Raluca
    Rusu, Florin
    Enache, Georgiana
    Popescu, Horatiu
    Posea, Mihaela
    Cursaru, Andrian
    Grosu, Larisa
    Radulian, Gabriela
    DIABETES, 2015, 64 : A128 - A128
  • [36] Reply to: "Diabetes mellitus as a risk factor of hepatocellular carcinoma in patients with chronic hepatitis B on nucleot(s)ide analogues"
    Hsu, Yao-Chun
    Yip, Terry Cheuk-Fung
    Wong, Grace Lai-Hung
    Wu, Chun-Ying
    JOURNAL OF HEPATOLOGY, 2019, 70 (04) : 796 - 797
  • [37] Sulfonylureas use and fractures risk in elderly patients with type 2 diabetes mellitus: a meta-analysis study
    Yujia Tao
    Meng E
    Jingjing Shi
    Zhen Zhang
    Aging Clinical and Experimental Research, 2021, 33 : 2133 - 2139
  • [38] DIABETES MELLITUS IS A RISK FACTOR FOR RECURRENCE AND MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA
    Vavallo, A.
    Lucarelli, G.
    Tedeschi, M.
    Impedovo, S., V
    Rutigliano, M.
    Bettocchi, C.
    Selvaggi, F. P.
    Battaglia, M.
    Ditonno, P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 139 - 140
  • [39] Sulfonylureas use and fractures risk in elderly patients with type 2 diabetes mellitus: a meta-analysis study
    Tao, Yujia
    Meng, E.
    Shi, Jingjing
    Zhang, Zhen
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (08) : 2133 - 2139
  • [40] Diabetes mellitus not an unfavorable factor on the prognosis of hepatitis C virus-related hepatocellular carcinoma
    Yoshida, Naoki
    Midorikawa, Yutaka
    Higaki, Tokio
    Nakayama, Hisashi
    Tsuji, Shingo
    Matsuoka, Shunichi
    Ishihara, Hisamitsu
    Moriyama, Mitsuhiko
    Takayama, Tadatoshi
    HEPATOLOGY RESEARCH, 2018, 48 (01) : 28 - 35
12345